Trade Organovo Holdings, Inc. - ONVO CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 0.53 |
Open | 0.55 |
1-Year Change | -68.02% |
Day's Range | 0.54 - 0.57 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 0.54 | -0.01 | -1.82% | 0.55 | 0.55 | 0.53 |
Jul 24, 2024 | 0.55 | -0.02 | -3.51% | 0.57 | 0.57 | 0.55 |
Jul 23, 2024 | 0.55 | -0.02 | -3.51% | 0.57 | 0.58 | 0.54 |
Jul 22, 2024 | 0.56 | -0.02 | -3.45% | 0.58 | 0.59 | 0.54 |
Jul 19, 2024 | 0.57 | -0.03 | -5.00% | 0.60 | 0.60 | 0.56 |
Jul 18, 2024 | 0.59 | 0.01 | 1.72% | 0.58 | 0.62 | 0.58 |
Jul 17, 2024 | 0.56 | -0.03 | -5.08% | 0.59 | 0.59 | 0.56 |
Jul 16, 2024 | 0.58 | -0.01 | -1.69% | 0.59 | 0.64 | 0.53 |
Jul 15, 2024 | 0.64 | 0.01 | 1.59% | 0.63 | 0.65 | 0.62 |
Jul 12, 2024 | 0.65 | -0.03 | -4.41% | 0.68 | 0.68 | 0.63 |
Jul 11, 2024 | 0.66 | -0.03 | -4.35% | 0.69 | 0.70 | 0.63 |
Jul 10, 2024 | 0.69 | -0.02 | -2.82% | 0.71 | 0.72 | 0.69 |
Jul 9, 2024 | 0.71 | -0.01 | -1.39% | 0.72 | 0.72 | 0.70 |
Jul 8, 2024 | 0.71 | -0.01 | -1.39% | 0.72 | 0.74 | 0.70 |
Jul 5, 2024 | 0.71 | -0.02 | -2.74% | 0.73 | 0.74 | 0.71 |
Jul 3, 2024 | 0.74 | 0.01 | 1.37% | 0.73 | 0.74 | 0.73 |
Jul 2, 2024 | 0.73 | -0.01 | -1.35% | 0.74 | 0.74 | 0.73 |
Jul 1, 2024 | 0.73 | -0.01 | -1.35% | 0.74 | 0.75 | 0.73 |
Jun 28, 2024 | 0.74 | 0.00 | 0.00% | 0.74 | 0.75 | 0.73 |
Jun 27, 2024 | 0.74 | 0.00 | 0.00% | 0.74 | 0.75 | 0.73 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Organovo Holdings, Inc. Company profile
About Organovo Holdings Inc
Organovo Holdings, Inc. is an early stage biotechnology company. The Company is focused on building high fidelity, three-dimensional (3D) tissues that recapitulate key aspects of human disease. The Company is targeting the intestine and has ongoing 3D tissue developments in Ulcerative colitis (UC) and Crohn's disease (CD). The Company uses its platform technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. NovoGen Bioprinters can dispense pure hydrogel formulations and also serve as important components of company's tissue prototyping and manufacturing platform. The Company also intends to use its bioprinting platform as well as 3D technologies to treat its target diseases.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Organovo Holdings Inc revenues was not reported. Net loss decreased 33% to $9.5M. Lower net loss reflects Non-cash stock-based compensation decrease of 78% to $1.2M (expense), Gain (loss) on fixed asset disposals decrease from $19K (expense) to $0K, Other income increase from $6K to $25K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$2.15 to -$1.10.
Equity composition
Common Stock $.0001 Par, 06/12 Shares auth.75M and o/s 43,772,483. Insiders 39.83%. 02/12, 10.59135-for-1 Stock split.
Industry: | Biotechnology & Medical Research (NEC) |
Suite 110
6275 Nancy Ridge Drive
SAN DIEGO
CALIFORNIA 92121
US
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com